Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families

Journal of Molecular Biology(2022)10.1016/j.jmb.2022.167626Source: DataRank Database

Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families is a research paper published in Journal of Molecular Biology (2022). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

gen pdb chembl

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 1.02)OA: greenTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Cynthia J. Meyer,Zhiwei Zhou ORCID,Ammar D. Elmezayen ORCID,Kenneth D. Westover ORCID,Lianbo Li ORCID

Live enrichment

PubMed:35595166 PMC:PMC9590303 OpenAlex:https://openalex.org/W4280544989

Cancer Prevention and Research Institute of Texas

Grant: RP220145

American Cancer Society

Grant: RSG-18-039-01

Welch Foundation

Grant: I1829

National Cancer Institute

Grant: R01 CA244341

National Cancer Institute

Grant: P30CA142543

National Institutes of Health

Grant: 5R01CA244341-03

Characterization and targeting of rapid nucleotide exchange RAS mutations

National Institutes of Health

Grant: 3P30CA142543-12S1

Multidimensional single-cell approach probing HIV-1 integration association with non-AIDS defining cancers (Biospecimens/Biocohort)

National Institutes of Health

Revolution Medicines

Astellas Pharma US

FWCI

1.02

Citation Percentile

0.7%

Citation Trend

2022

2024

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9590303

publisherhttps://api.elsevier.com/content/article/PII:S0022283622002066?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022283622002066?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jmb.2022.167626

Fields of Study

Protein Kinase Regulation and GTPase SignalingProtein Tyrosine PhosphatasesPeptidase Inhibition and Analysis0301 basic medicine0303 health sciences03 medical and health sciencesAntineoplastic AgentsCysteineHumansMolecular Targeted TherapyNeoplasmsProtein Kinase InhibitorsProtein Kinasesras Proteins

MeSH Terms

Antineoplastic AgentsCysteineHumansNeoplasmsProtein Kinasesras ProteinsProtein Kinase InhibitorsMolecular Targeted Therapy

Keywords

Allosteric regulationDrug discoveryComputational biologyKinaseChemistryCysteineBiochemistryPharmacologyBiologyEnzymeKinase InhibitorAllosteric InhibitorCovalent InhibitorCysteinomeKras InhibitorNeoplasmsras ProteinsHumansAntineoplastic AgentsMolecular Targeted TherapyProtein Kinase InhibitorsProtein Kinases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Therapeutic Targeting the Allosteric Cysteinome of RAS and Kinase Families

FAIR Checklist

Authors (5)

Funding (10 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)